Skip to main content
Sirnaomics Ltd. logo

Sirnaomics Ltd. — Investor Relations & Filings

Ticker · 2257 LEI · 2549004JEEDTBC6EHW37 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 402 across all filing types
Latest filing 2024-12-02 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 2257

About Sirnaomics Ltd.

http://www.sirnaomics.com

Sirnaomics Ltd. is a clinical-stage RNA therapeutics biopharmaceutical company focused on discovering and developing innovative drugs for indications with significant unmet medical needs. The company's pipeline addresses a broad spectrum of therapeutic areas, including oncology, fibrosis-related diseases, skin conditions, antiviral and cardiometabolic diseases, and medical aesthetics. Sirnaomics utilizes proprietary delivery platforms, which form the foundation of its RNA-based therapeutics. These platforms include the Polypeptide Nanoparticle (PNP) system for administering mRNA vaccines and therapeutics, and the GalNAc delivery platform for systemic administration of liver-targeting RNA interference (RNAi) therapeutics. The company is recognized as the first to achieve positive Phase IIb clinical outcomes in oncology using clinical-stage RNA therapeutics.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Share Issue/Capital Change Classification · 1% confidence The document is a “Next Day Disclosure Return” (Form FF305) filed under Hong Kong Listing Rules, detailing changes in issued shares of Sirnaomics Ltd. on 2 December 2024 (placement/subscription of new shares). It reports an increase of 17,527,696 new ordinary shares pursuant to a general mandate subscription agreement. This is a direct announcement of a share issue/capital change event, fitting the category for Share Issue/Capital Change (SHA), not a broader annual or interim report, management discussion, or regulatory fallback. Thus, the correct classification is SHA.
2024-12-02 English
CHANGE OF COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT
Board/Management Information Classification · 1% confidence The document is an announcement regarding executive management changes – specifically the resignation of the company secretary, authorized representative and process agent, and the appointment of their replacement. This clearly fits the definition of a Board/Management Information announcement (Code: MANG).
2024-12-01 English
FURTHER DELAY IN DESPATCH OF CIRCULAR
Report Publication Announcement Classification · 1% confidence The document is a listing announcement by Sirnaomics Ltd. regarding a further delay in the despatch of a circular for an extraordinary general meeting (EGM). It does not contain substantive report content itself but rather notifies shareholders of the timing for mailing the circular. This fits the definition of a Report Publication Announcement, which covers announcements about the timing or release of company reports.
2024-11-29 English
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 1% confidence The document is a formal announcement by Sirnaomics Ltd. regarding the resignation of an independent non-executive director from the Board, Audit Committee, and Nomination Committee, effective January 1, 2025. This constitutes a change in the company's board of directors and fits the definition of a Board/Management Information filing.
2024-11-27 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Regulatory Filings
2024-11-05 English
CHANGE OF CHIEF EXECUTIVE OFFICER AND RE-DESIGNATION OF DIRECTOR
Regulatory Filings
2024-11-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.